Weight loss induced by orlistat reverses fatty infiltration and improves hepatic fibrosis in obese patients with non-alcoholic steatohepatitis. [electronic resource]
Producer: 20070404Description: 443-4 p. digitalISSN:- 0017-5749
No physical items for this record
Publication Type: Clinical Trial; Letter
There are no comments on this title.
Log in to your account to post a comment.